Masthead
21 April 2022
Identification of the chloride channel, leucine‐rich repeat‐containing protein 8, subfamily a (LRRC8A), in mouse cholangiocytes
Nikolay Shcheynikov, Kristy Boggs, Anthony Green, Andrew P. Feranchak – 20 April 2022
CAQ Corner: Long‐term medical complications of liver transplantation
Monica Tincopa – 20 April 2022
First‐line therapies for hepatitis B in the United States: A 3‐year prospective and multicenter real‐world study after approval of tenofovir alefenamide
Calvin Q. Pan, Nezam H. Afdhal, Victor Ankoma‐Sey, Ho Bae, Michael P. Curry, Douglas Dieterich, Lynn Frazier, Andrew Frick, Hie‐Won Hann, W. Ray Kim, Paul Kwo, Scott Milligan, Myron J. Tong, K. Rajender Reddy – 20 April 2022 – Real‐world data are limited on tenofovir alafenamide (TAF). We aimed to study TAF real‐world outcomes with other first‐line regimens for chronic hepatitis B (CHB). We enrolled patients with CHB from 10 centers retrospectively and followed them for 36 months prospectively.
Neutralization and receptor use of infectious culture–derived rat hepacivirus as a model for HCV
Raphael Wolfisberg, Caroline E. Thorselius, Eduardo Salinas, Elizabeth Elrod, Sheetal Trivedi, Louise Nielsen, Ulrik Fahnøe, Amit Kapoor, Arash Grakoui, Charles M. Rice, Jens Bukh, Kenn Holmbeck, Troels K. H. Scheel – 20 April 2022
Letter to the editor: A revised electronic version of RUCAM for the diagnosis of drug‐induced liver injury
Harshad Devarbhavi, Sunu Sara Kurien – 20 April 2022
Intraoperative intracardiac thrombus in liver transplantation: A 9‐year retrospective review focusing on treatment and outcomes
Erica Fagelman, Ryan Wang, Amanda Tomlinson, Diana Romano, Nicolette Schlichting, Jeron Zerillo, Samuel DeMaria,, Natalie K. Smith – 20 April 2022 – This study characterizes incidence and outcomes surrounding intracardiac thrombosis (ICT) during liver transplantation over 9 years at a single center before and after the routine use of transesophageal echocardiography (TEE). Adult liver transplantation patients from 2011 to 2020 were divided into eras based on routine TEE use. ICTs were identified by querying anesthetic records for search terms.
CAQ Corner: Long‐term medical complications of liver transplantation
Monica Tincopa – 20 April 2022
Long‐term outcome of primary percutaneous stent angioplasty for pediatric posttransplantation portal vein stenosis
Mila Bukova, Dominik Funken, Eva‐Doreen Pfister, Ulrich Baumann, Nicolas Richter, Florian F. W. Vondran, Christoph M. Happel, Harald Bertram – 20 April 2022 – This study aims to evaluate the long‐term efficacy and reintervention rate after primary percutaneous portal vein stent angioplasty for portal vein stenosis (PVS) in pediatric liver transplantation (LT) recipients. From 2004 to 2020, a total of 470 pediatric LTs were performed in our center. All cases were screened for interventional PVS treatment and analyzed retrospectively.